China Life(SH:601628) 券商中国·2026-01-25 12:12Core Viewpoint - The article highlights China Life's significant investment plans in the equity market, focusing on a total commitment of nearly 12.5 billion yuan in two funds targeting the aging industry and technology innovation in the Yangtze River Delta region [1][4]. Group 1: Investment in Aging Industry Fund - China Life plans to invest approximately 8.5 billion yuan in a second phase of the Beijing Guoshou Aging Industry Equity Investment Fund, with a total commitment of 8.4915 billion yuan from China Life and 0.0085 billion yuan from Guoshou Qiyuan [2]. - The fund will focus on investments in the aging industry, utilizing a combination of light and heavy asset strategies, emphasizing "strategic allocation, value investment, and long-term investment" [2]. - The investment aims to enhance asset management and operational income through acquisitions of existing aging real estate projects and the expansion of new projects, contributing to the construction of the Guoshou health ecosystem [2]. Group 2: Investment in Yangtze River Delta Technology Innovation Fund - China Life is set to invest 4 billion yuan in the Huizhi Yangtze River Delta (Shanghai) Private Fund Partnership, with a total commitment of 5.0515 billion yuan from all partners [3]. - The fund will primarily target technology innovation companies in three leading sectors: artificial intelligence, integrated circuits, and biomedicine, with at least 70% of the investment allocated to artificial intelligence [3]. - Key focus areas within artificial intelligence include smart chips, intelligent software, and AI infrastructure, aligned with the "5+6" strategic framework for technological innovation [3]. Group 3: Broader Context of Insurance Capital Investment - The investments are part of a broader trend where insurance companies are increasing their equity investment activities, with 22 equity investment plans registered in 2025, totaling 33.532 billion yuan, and 7 private equity funds with a total of 35.006 billion yuan [5][8]. - China Life's transactions align with national strategic directions, aiming to enhance investment returns and capture opportunities from technological innovation, thereby improving the quality and returns of equity investment layouts [4].